1. Home
  2. XRTX vs CAPS Comparison

XRTX vs CAPS Comparison

Compare XRTX & CAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • CAPS
  • Stock Information
  • Founded
  • XRTX 2011
  • CAPS 1987
  • Country
  • XRTX Canada
  • CAPS United States
  • Employees
  • XRTX N/A
  • CAPS N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • CAPS
  • Sector
  • XRTX Health Care
  • CAPS
  • Exchange
  • XRTX Nasdaq
  • CAPS NYSE
  • Market Cap
  • XRTX 3.0M
  • CAPS 3.0M
  • IPO Year
  • XRTX N/A
  • CAPS N/A
  • Fundamental
  • Price
  • XRTX $0.96
  • CAPS $2.36
  • Analyst Decision
  • XRTX
  • CAPS
  • Analyst Count
  • XRTX 0
  • CAPS 0
  • Target Price
  • XRTX N/A
  • CAPS N/A
  • AVG Volume (30 Days)
  • XRTX 16.6K
  • CAPS 1.0M
  • Earning Date
  • XRTX 05-16-2025
  • CAPS 04-02-2025
  • Dividend Yield
  • XRTX N/A
  • CAPS N/A
  • EPS Growth
  • XRTX N/A
  • CAPS N/A
  • EPS
  • XRTX N/A
  • CAPS N/A
  • Revenue
  • XRTX N/A
  • CAPS $44,876,000.00
  • Revenue This Year
  • XRTX N/A
  • CAPS N/A
  • Revenue Next Year
  • XRTX N/A
  • CAPS N/A
  • P/E Ratio
  • XRTX N/A
  • CAPS N/A
  • Revenue Growth
  • XRTX N/A
  • CAPS N/A
  • 52 Week Low
  • XRTX $0.82
  • CAPS $1.72
  • 52 Week High
  • XRTX $3.92
  • CAPS $16.18
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 49.57
  • CAPS N/A
  • Support Level
  • XRTX $0.90
  • CAPS N/A
  • Resistance Level
  • XRTX $1.10
  • CAPS N/A
  • Average True Range (ATR)
  • XRTX 0.08
  • CAPS 0.00
  • MACD
  • XRTX -0.00
  • CAPS 0.00
  • Stochastic Oscillator
  • XRTX 38.60
  • CAPS 0.00

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About CAPS CAPSTONE HOLDING CORP

Capstone Holding Corp operates through its wholly-owned subsidiary as a construction materials company, which distributes manufactured and natural stone cladding products, natural stone landscape products, and related goods for residential and commercial construction.

Share on Social Networks: